Clinical trials recruiting in Middlesex, United Kingdom
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 2Phase 3 3Not applicable 2
Conditions recruiting in Middlesex, United Kingdom
Recruiting trials in Middlesex, United Kingdom
- A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
- Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers
- Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Common questions
How many clinical trials are recruiting in Middlesex, United Kingdom?
7 recruiting trials have at least one study site in Middlesex, United Kingdom.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.